ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB)
Financial Services › National Commercial Banks
Price History
Feb 9, 2026 — May 18, 2026Investment Snapshot
- Trading 6% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 4.0% — below-average profitability
ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is a Financial Services company operating in National Commercial Banks, listed on the ARCA , with a market capitalisation of $89.5 billion . Key value metrics: P/E ratio 25.1, P/B ratio 1.00, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
ETRACS Alerian MLP Index ETN Series B due July 18, 2042 — Fundamental Analysis Summary
ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is currently trading 6% above its Graham Number of $21.92, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.1x.
On financial health, AMUB shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 4.0% (sector average: 4.9%), and high leverage with a debt-to-equity ratio of 16.63.
StockPik's composite Value Score for AMUB is 62/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AMUB shows earnings growing at 133%.